Losortan Potassium Tablet, Film Coated
Product Images NDC 71335-1644

6 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 71335-1644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 01)

Losapotatab1 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 01)
Chemical structure of Losartan Potassium, illustrating the molecular arrangement including a chlorinated imidazole ring, biphenyl group, and potassium ion (K+).*
FDA Label Image

Losapotatab2 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02)

Losapotatab2 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02)
A line graph comparing the percentage of patients with a primary endpoint over study months for Atenolol and Losartan Potassium. The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients from 0 to 16. The graph indicates an adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Losapotatab3 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03)

Losapotatab3 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03)
A line graph comparing the percentage of patients with fatal or non-fatal stroke over a 66-month study period for Atenolol and Losartan Potassium. The graph shows Atenolol as a dashed line and Losartan Potassium as a solid line, indicating a lower percentage of stroke patients with Losartan Potassium. The graph notes an adjusted risk reduction of 25% with a p-value of 0.001.*
FDA Label Image

Losapotatab (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04)

Losapotatab (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04)
A forest plot chart showing hazard ratios with 95% confidence intervals comparing Losartan-K and Atenolol for primary composite outcomes and stroke (fatal/non-fatal) across various patient subgroups including age, gender, race, ischemic heart status, diabetes, and history of cardiovascular disease. The chart includes event rates and visually represents which drug is favored within each subgroup.*
FDA Label Image

Losapotatab5 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05)

Losapotatab5 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05)
A line graph showing the percentage of patients with an event over 48 months comparing Losartan Potassium Tablet and placebo. The graph indicates a risk reduction of 16.1% with Losartan Potassium, with p=0.022, with time on the x-axis (months) and percent of patients on the y-axis.*
FDA Label Image

Label (Lbl713351644)

Label (Lbl713351644)
Losartan Potassium 25 mg film-coated tablet label by Bryant Ranch Prepack. The label indicates this product contains 90 tablets and compares to Cozaar 25 mg tablet from Cadila Healthcare Ltd. Storage instructions specify room temperature between 20°-25°C (68°-77°F). The label includes lot number 1523487 and NDC 71335-1644-1, with a barcode visible at the bottom right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.